At Robinson Bradshaw, my focus is empowering fund managers with robust strategies for fund offerings and operational management. I also guide numerous institutional stakeholders, state pension plans, and private investment entities toward protecting their interests as they invest in private equity and alternative investment ventures. Such guidance has forged a path for innovation and prudent investment in dynamic markets for my clients on both the investor and sponsor side of the private funds space.Leveraging over ten years of legal experience, I specialize in intellectual property within health care and life sciences, supporting clients with software licensing and technology development counsel to efficiently mitigate risks, including protecting valuable intellectual property rights and streamlining contracting approaches for technology vendors and assisting technology consumers in maximizing contractual protection for mission-critical technology licensing arrangement. My expertise in navigating domestic and international data privacy laws is a testament to my comprehensive approach, ensuring that our clients' proprietary advancements are safeguarded and strategically positioned for success.Prior to becoming an attorney, I was a molecular biologist, focused on sales and product support across the biotechnology and pharmaceutical research and development spectrum. My industry experience spanned numerous technologies, including, but not limited to, DNA sequencing (during the height and culmination of the Human Genome Project, an exciting time in that space to say the least), assisting the North Carolina State Bureau of Investigation in developing an automated protocol to “catch up” the backlog for all felon DNA typing, designing and implementing automated solutions for laboratories across the United States, and data analytic software for pharmaceutical research and clinical development.